Professor
Director of the Program for Global Public Health and the Common Good
Assistant Director of the Center for Child and Family Policy
McGuinn Hall 210
Telephone: 617-552-0945
Email: summer.hawkins@bc.edu
Social epidemiology
Policy evaluation
Health disparities
Tobacco use
Cannabis use
Maternal morbidity
BCSSW News: What happens when states ban the sale of flavored tobacco products?
BCSSW News: Undergraduate student researchers confront ‘messy reality’ of the real world
BC News:Â Hawkins is new head of BC Global Public Health and the Common Good Program
Professor Summer Sherburne Hawkins, PhD, MS, joined the Boston College School of Social Work (BCSSW) faculty in 2012. She is a social epidemiologist with an interest in addressing policy-relevant research questions in women’s and children’s health. Her research examines the impact of policies on health disparities in parents and children, particularly using methodology that integrates epidemiology and economics. She uses applied econometric techniques to evaluate natural experiments created through policy changes within and between US states, including substance use policies, reproductive health-related policies, breastfeeding policies, and the Patient Protection and Affordable Care Act. Professor Hawkins has published extensively in peer-reviewed public health journals on the topics of tobacco and cannabis use, maternal morbidity and mortality, infant feeding practices, and preventive health services as well as the impact of state policies on disparities in these health behaviors and outcomes.
Dr Hawkins is leading two studies funded by the National Institutes of Health examining how the rapidly changing cannabis policy landscape is influencing substance use during pregnancy. The first is a four-year study in the state of Maine, which provides an important natural experiment to understand the trajectory of cannabis use among pregnant women following the legalization of recreational cannabis in 2017 and the introduction of retail sales in 2020, which required municipalities to opt in. Through a novel data linkage of individual-level survey data on prenatal substance use, birth certificates, and health insurance claims, we will rigorously evaluate the effects of state- and county-level recreational cannabis policies on women’s cannabis, tobacco, and alcohol use before, during, and after pregnancy and, subsequently, on birth outcomes and maternal and child health outcomes . The second project is a two-year study using the Pregnancy Risk Assessment Monitoring System to examine the effects of state recreational cannabis laws on women’s use of cannabis, tobacco, and alcohol during pregnancy, birth outcomes, and health care providers’ assessment of prenatal substance use Both studies use quasi-experimental methods to rigorously evaluate policy effects overall and across higher-risk groups with the aim of informing public health and policy responses to the cannabis policy environment.
Dr. Hawkins is the Director for the Global Public Health and the Common Good program and the Assistant Director of the Center for Child and Family Policy at Boston College. She also serves as the Chair of SACRU on Gender Equity in the University and as an Associate Editor for the Journal of Epidemiology & Community Health. Prior to joining the BCSSW, Professor Hawkins was a Cohort 7 Robert Wood Johnson Health & Society Scholar at the Harvard T.H. Chan School of Public Health from 2009-2011.
Hawkins SS, Coley RL, Baum CF. Impact of recreational cannabis legalization on disparities in prenatal use and co-use of tobacco and cannabis. Nicotine & Tobacco Research 2026; Jun 19:ntag138. PMID: 42319037
Hawkins SS, Baidoo CE, Coley RL, Centanni RS, Baum CF. The impact of recreational cannabis legalization on cannabis use in US adults from 2016-2023: A quasi-experimental study. American Journal of Preventive Medicine 2026 70(5):108221. PMID: 41543466
Hawkins SS, Baum CF. Associations between local cigarette and e-cigarette prices and smoke-free legislation with prenatal smoking and birth outcomes. Drug and Alcohol Dependence 2025;274:112777. PMID: 40652608
Holland E, Joseph NT, Salas-Wright CP, Hacker MR, Hawkins SS. Racial and ethnic differences in self-reported substance use and screening during prenatal care. American Journal of Obstetrics & Gynecology Maternal Fetal Medicine 2025;7(5):101660. PMID: 40032180
Hawkins SS, Carey N, Coley RL, Baum CF. Associations between tobacco 21 and flavor restrictions with young adult tobacco use. Tobacco Control 2025;34(5):571-578. PMID: 38527790 PMCID: PMC11693773
Hawkins SS, Harper S, Baum CF, Kaufman JS. Associations between state-level changes in reproductive health services and indicators of severe maternal morbidity. JAMA Pediatrics 2023;177(1):93-95. PMID: 36374506 PMCID: PMC9664365
Hawkins SS, Baum CF. Invited commentary: Evaluating intersectionality of policies and populations. Pediatrics 2021;147(5):E2020049586. doi:10.1542/peds.2020-049586Â PMID: 33875538.
06/2026-05/2030 National Institute on Drug Abuse (1R01DA066717) – titled, Evaluating the effects of recreational cannabis policies on prenatal cannabis use and maternal and child health outcomes for real-world impact
Role: Principal Investigator
05/2026-04/2028 National Institute on Drug Abuse (R03DA063982) – titled, Effects of recreational cannabis laws on disparities in prenatal substance use
Role: Principal Investigator
09/2025-05/2028 National Institute of Child Health and Human Development (R01HD117959) – titled, State differences in the effects of policy change on maternal health
Role: Co-Investigator (PI: Joanna Venator)
07/2024-06/2025 Office of the Vice Provost for Research RADS (Research Across Departments & Schools) grant – titled, Prenatal substance use laws and recreational cannabis legalization: A mixed methods study of their effects on women and health care providers
Role: Principal Investigator
06/2024-12/2025 Robert Wood Johnson Foundation’s (RWJF) Health Data for Action (HD4A) program – titled, Impacts of abortion restrictions on fertility and maternal morbidity outcomes
Role: Co-Investigator (PI: Joanna Venator)
09/2021-08/2023 National Cancer Institute & FDA Center for Tobacco Products (R21CA268199) – titled, Impact analysis of flavor restrictions and tobacco 21 policies on youth tobacco use
Role: Principal Investigator
Visiting Associate Professor, Department of Global Health & Social Medicine, King’s College London, England (09/18-08/19)
K99/R00 recipient – National Institute of Child Health and Human Development, 5-year career development award (R00HD068506) (2011-2016)